Home » Stocks » Quotient

Quotient Limited (QTNT)

Stock Price: $6.63 USD -0.12 (-1.78%)
Updated Aug 12, 2020 2:24 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 534.66M
Revenue (ttm) 33.41M
Net Income (ttm) -104.63M
Shares Out 80.64M
EPS (ttm) -1.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $6.63
Previous Close $6.75
Change ($) -0.12
Change (%) -1.78%
Day's Open 6.82
Day's Range 6.60 - 6.99
Day's Volume 247,402
52-Week Range 2.40 - 11.10

More Stats

Market Cap 534.66M
Enterprise Value 610.59M
Earnings Date (est) Nov 9, 2020
Ex-Dividend Date n/a
Shares Outstanding 80.64M
Float 46.87M
EPS (basic) -1.4
EPS (diluted) -1.39
FCF / Share -1.05
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 6.45M
Short Ratio 9.20
Short % of Float 8.72%
Beta 2.60
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 16.00
PB Ratio 31.00
Revenue 33.41M
Operating Income -81.99M
Net Income -104.63M
Free Cash Flow -84.69M
Net Cash -75.93M
Net Cash / Share -0.94
Gross Margin 44.46%
Operating Margin -245.40%
Profit Margin -313.20%
FCF Margin -253.48%
ROA -25.36%
ROE -489.97%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$13.50*
(103.62% upside)
Low
13.0
Current: $6.63
High
14.0
Target: 13.50
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue32.6629.1324.7322.2318.5218.4119.7614.3712.2210.03
Revenue Growth12.09%17.8%11.27%20%0.62%-6.82%37.46%17.61%21.78%-
Gross Profit14.8611.9014.2611.388.868.6511.357.205.474.41
Operating Income-80.69-78.96-69.99-74.06-49.09-29.71-8.89-4.49-3.96-4.10
Net Income-103-105-82.34-85.07-33.88-59.06-10.17-4.71-4.47-4.62
Shares Outstanding71.6154.8740.8428.1519.5614.770.190.070.060.06
Earnings Per Share-1.44-1.92-2.02-3.02-1.73-4.00-54.41-62.97-78.04-81.16
Operating Cash Flow-80.65-75.66-68.42-56.20-46.97-26.59-4.38-3.62-3.07-3.56
Capital Expenditures-4.60-4.79-1.86-20.16-28.91-23.85-7.23-0.89-0.35-0.09
Free Cash Flow-85.24-80.45-70.28-76.36-75.88-50.45-11.61-4.51-3.42-3.65
Cash & Equivalents13010230.8725.8544.1037.537.194.224.350.00
Total Debt17812387.0082.2530.7914.8715.443.513.10-
Net Cash / Debt-47.88-20.86-56.13-56.4013.3222.66-8.250.711.260.00
Assets22617812411012080.2029.8112.8912.36-
Liabilities23217613813473.0381.8230.587.937.29-
Book Value-5.531.71-14.63-24.0946.72-1.62-31.54-23.06-18.69-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Quotient Limited
Country Switzerland
Employees 420
CEO Franz Walt

Stock Information

Ticker Symbol QTNT
Stock Exchange NASDAQ
Unique Identifier NASDAQ: QTNT
IPO Date April 25, 2014

Description

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company is also developing microarray-based SARS-CoV-2 antibody test for use on the MosaiQ platform for COVID-19. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.